Candriam Equities L Oncology Impact I/ LU1864482515 /
| NAV2024-05-15 | Chg.+14.5801 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,253.8301GBP | +0.65% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | 10.22 | 10.74 | 1.48 | -1.69 | 0.14 | 7.21 | -2.22 | 2.49 | 1.44 | - |
| 2021 | 0.09 | -5.90 | 1.24 | 1.97 | -2.18 | 6.26 | -1.59 | 6.66 | -1.78 | 1.68 | -2.99 | 1.57 | +4.39% |
| 2022 | -9.64 | -1.76 | 6.66 | -1.27 | -1.71 | 3.82 | 4.16 | 1.30 | -0.67 | 3.78 | 2.55 | -4.40 | +1.72% |
| 2023 | -0.19 | -2.26 | -0.73 | 1.15 | -1.18 | -2.43 | -0.31 | -0.51 | -1.63 | -5.81 | 4.68 | 5.01 | -4.59% |
| 2024 | 1.47 | 4.84 | 1.63 | -2.53 | 3.85 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 11.17% | 11.10% | 11.57% | 14.44% | -% |
| Sharpe ratio | 2.15 | 2.93 | 0.09 | 0.11 | - |
| Best month | +5.01% | +5.01% | +5.01% | +6.66% | +10.74% |
| Worst month | -2.53% | -2.53% | -5.81% | -9.64% | -9.64% |
| Maximum loss | -4.95% | -4.95% | -13.99% | -18.83% | - |
| Outperformance | - | - | - | - | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,398.6299 | +6.39% | +5.95% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,563.0500 | +6.52% | +6.35% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.8000 | +2.84% | -4.95% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,253.8301 | +4.88% | +17.16% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,609.7900 | +6.05% | +4.94% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.5300 | +5.14% | +14.13% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.0700 | +5.05% | +2.03% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.1500 | +5.95% | +4.63% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,789.0000 | +2.14% | +2.29% | |
| Candriam Equities L Oncology Imp... | reinvestment | 159.4500 | +4.76% | +16.76% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,112.6001 | +3.81% | -2.23% | |
| Candriam Equities L Oncology Imp... | reinvestment | 260.1300 | +6.03% | +17.04% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.3000 | +2.43% | -6.06% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.6200 | +5.94% | +4.62% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.0400 | +3.70% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,858.9600 | +5.22% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,881.4299 | +6.05% | +4.94% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.8600 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 274.2800 | +5.05% | +2.02% |
Performance
| YTD | +9.44% | ||
|---|---|---|---|
| 6 Months | +16.60% | ||
| 1 Year | +4.88% | ||
| 3 Years | +17.16% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +50.26% | ||
| Year | |||
| 2023 | -4.59% | ||
| 2022 | +1.72% | ||
| 2021 | +4.39% | ||
